Dermatology, Nasal Sprays Among Emerging OTC Switch Categories
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA threw the switch floodgates open with the NSURE initiative and it has fueled interest with the recent first-in-class switches of Nasacort and Oxytrol for Women. Likely categories for successful switches include dermatology, nasal sprays in allergy, sleep, migraine relief and cholesterol management.